Nervonik: Valuation, Funding & Investors
Nervonik is a medical device company specializing in the development of an opioid-free peripheral nerve stimulation (PNS) system. The company's innovative approach aims to provide effective pain management solutions without the use of opioids, addressing a critical need in the healthcare industry.
Leadership & Board
- Current Number of Employees
- 28
- Current LinkedIn Followers
- 6,335
Latest Estimated Valuation
- Total Amount Raised
- $66M
- Total Funding Rounds
- 2
- Latest Funding Amount
- $53M
- Latest Funding Round
- Series B
Employee Trend
Nervonik had 28 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.
28Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Nervonik had 6,335 followers as of November 9, 2026. The number of followers increased by 113 (1.82%) week-over-week.
6,335Latest Followers Count
113(1.82%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Apr 27, 2026 | Series B | $52.50M | ― |
| Mar 04, 2025 | Series A | $13.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Amzak Health | Series B |
| Elevage Medical Technologies | Series B |
| U.S. Venture Partners | Series B |
| Lumira Ventures | Series B |
| Foothill Ventures | Series B |
| Shangbay Capital | Series B |
| U.S. Venture Partners | Series A |
| Correlation Ventures | Series A |
Similar Companies
A snapshot of private companies similar to Nervonik, helping you discover and navigate related company profiles.
Related News and Analysis
